These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3020838)

  • 1. [A hitherto unknown reaction pattern in vertebrate cells (RiV). 2. The protective effect of RiV particle preparations against foot-and-mouth disease in guinea pigs].
    Solisch P; Nöckler A; Schäfer D; Riebe R; Holl U; Schirrmeier H; Kretzschmar C; Wazel W; Dietz G; Sulk J
    Zentralbl Allg Pathol; 1986; 131(6):563-8. PubMed ID: 3020838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1.
    Rao MG; Butchaiah G; Sen AK
    Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccines.
    Doel TR; Collen T
    J Biol Stand; 1982 Apr; 10(2):69-81. PubMed ID: 6284761
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus.
    Doel TR; Chong WK
    Arch Virol; 1982; 73(2):185-91. PubMed ID: 6293410
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protective effect in the serum of rabbits inoculated with BHK-21 cells infected with foot-and-mouth disease virus].
    Brunengo AM; Massouh EJ; Ubogui JL
    Rev Argent Microbiol; 1979; 11(1):14-21. PubMed ID: 231797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
    Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
    Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis.
    Roeder PL; Le Blanc Smith PM
    Res Vet Sci; 1987 Sep; 43(2):225-32. PubMed ID: 2825310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response against foot and mouth disease virus (FMDV). Part II: Responses measured in fractionated sera of infected steers with complete virus, trypsin treated virus, 12 S virus subunits, VIA and heterologous virus.
    Meloen RH
    Zentralbl Veterinarmed B; 1979 Jul; 26(5):358-65. PubMed ID: 93833
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
    Vol'pina OM; Surovoi AYu ; Ivanov VT
    Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Langerhans cells in the infection of the guinea-pig epidermis with foot-and-mouth disease virus.
    di Girolamo W; Salas M; Laguens RP
    Arch Virol; 1985; 83(3-4):331-6. PubMed ID: 2982360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.
    Cartwright B; Chapman WG; Brown F
    J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiments on an early protection against foot-and-mouth disease virus.
    Liebermann HT; Thalmann G; Bartels T; Nöckler A
    Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological study of type A Indian foot-and-mouth disease virus isolates.
    Meer Azad H; Srinivasan VA; Crowther JR
    Acta Virol; 1995 Sep; 39(4):193-6. PubMed ID: 8825299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible use of native foot-and-mouth disease non-structural protein 3A in a serological screening test.
    Dekker A; Gijsen E
    Vet Q; 1998; 20 Suppl 2():S27-8. PubMed ID: 9652060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the immune response against mixotope peptide libraries from a main antigenic site of foot-and-mouth disease virus.
    Oliveira Ed; Jiménez-Clavero MA; Núñez JI; Sobrino F; Andreu D
    Vaccine; 2005 Apr; 23(20):2647-57. PubMed ID: 15780448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
    Yao Q; Qian P; Huang Q; Cao Y; Chen H
    J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.